The US Food and Drug Administration (FDA) on Thursday issued new draft guidance meant to establish the necessary performance characteristics for genetic sequencing tests used to diagnose infectious ...

This enables next-day reporting and greater batch efficiency for high-throughput hospital needs. Combined with a simplified report format that combines the results of both qPCR and NGS tests, the ...

If you've ever taken an at-home diagnostic test for COVID-19, you can partially credit the technology to the Johns Hopkins University Center for Innovative Diagnostics for Infectious Diseases (CIDID).

Pregnancy care is now being transformed from its traditional, observational monitoring approach into a proactive, precision-led process, thanks to antenatal genomics.

Oct 3 (Reuters) - The World Health Organization authorized Abbott Laboratories' (ABT.N), opens new tab mpox diagnostic test for emergency use on Thursday, the first such approval in the agency's ...

A key microbial genome database is being updated and expanded through a public-private partnership, as the US Food and Drug Administration (FDA) works with a health data company and an academic ...

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today announced that it looks forward to working with the U.S.

"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...

The FDA approved the Oncomine Dx Target Test for identifying HER2-mutant NSCLC patients eligible for Hernexeos, an oral tyrosine kinase inhibitor. Hernexeos offers a new treatment option for ...